Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
38.9M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$47.9M
-
Put/Call ratio
-
0.3
-
Number of buys
-
78
-
Number of sells
-
-72
-
Price
-
$41.73
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2016
192 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2016.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.9M shares
of 58.6M outstanding shares and own 66.33% of the company stock.
Largest 10 shareholders include FMR LLC (6.3M shares), WELLINGTON MANAGEMENT GROUP LLP (5.88M shares), BB BIOTECH AG (2.81M shares), Capital International Investors (2.8M shares), VANGUARD GROUP INC (2.47M shares), Clearbridge Investments, LLC (1.54M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.29M shares), STATE STREET CORP (1.24M shares), Flagship Pioneering Inc. (965K shares), and BlackRock Fund Advisors (917K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.